Genetics of hereditary hemochromatosis: A clinical perspective
MetadataShow full item record
Hereditary hemochromatosis due to homozygosity for the C282Y mutation in the HFE gene product is the most common autosomal recessive genetic disorder in populations of northern European descent, where it attains a maximum prevalence of approximately one in 200. Cross-sectional and longitudinal studies have revealed that clinically significant iron-overload disease develops in at least 28% of male and 1% of female HFE C282Y homozygotes. The relatively low clinical penetrance is largely unexplained. Current evidence suggests a limited role for digenic inheritance of mutations in iron homeostasis genes in modifying the penetrance of hemochromatosis. Male gender is a strong genetic factor, promoting expression of clinical disease. Dietary intake of alcohol and noncitrus fruit may also act as important environmental modifiers of penetrance. With genetic analyses becoming simpler to perform, new genetic modifiers of hepatic iron loading and liver fibrogenesis are likely to be forthcoming. © 2009 Expert Reviews Ltd.
Showing items related by title, author, creator and subject.
Alawadhi, Sohaila (2010)Background: According to the United Kingdom prospective diabetes study, metformin is considered the drug of choice in overweight newly diagnosed type 2 diabetic patients. Metformin is well characterized as a substrate of ...
The rare and undiagnosed diseases diagnostic service - application of massively parallel sequencing in a state-wide clinical service.Baynam, G.; Pachter, N.; McKenzie, F.; Townshend, S.; Slee, J.; Kiraly-Borri, C.; Vasudevan, A.; Hawkins, A.; Broley, S.; Schofield, L.; Verhoef, H.; Walker, C.; Molster, C.; Blackwell, J.; Jamieson, S.; Tang, D.; Lassmann, T.; Mina, K.; Beilby, J.; Davis, M.; Laing, N.; Murphy, L.; Weeramanthri, T.; Dawkins, Hugh; Goldblatt, J. (2016)BACKGROUND: The Rare and Undiagnosed Diseases Diagnostic Service (RUDDS) refers to a genomic diagnostic platform operating within the Western Australian Government clinical services delivered through Genetic Services of ...
Rousseau, F.; Lindsay, C.; Charland, M.; Labelle, Y.; Bergeron, J.; Blancquaert, I.; Delage, R.; Gilfix, B.; Miron, M.; Mitchell, G.; Oligny, L.; Pazzagli, M.; Mamotte, Cyril; Payne, D. (2010)Background: The completion of the Human Genome Project has increased the pace of discovery of genetic markers for disease. Despite tremendous efforts in fundamental research, clinical applications still lag behind ...